These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 171200)

  • 21. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.
    Del Buono R; Wenzl TG; Ball G; Keady S; Thomson M
    Arch Dis Child; 2005 May; 90(5):460-3. PubMed ID: 15851425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of medical management of gastroesophageal reflux: a critical assessment.
    Hollander D; Karris G
    South Med J; 1978 Jan; 71 Suppl 1():41-2. PubMed ID: 204059
    [No Abstract]   [Full Text] [Related]  

  • 23. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.
    Buts JP; Barudi C; Otte JB
    Eur J Pediatr; 1987 Mar; 146(2):156-8. PubMed ID: 3032640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gaviscon and gastroesophageal reflux in children.
    Buts JP; Leclercq V
    J Pediatr Gastroenterol Nutr; 1987; 6(3):482-3. PubMed ID: 2828595
    [No Abstract]   [Full Text] [Related]  

  • 25. [Gaviscon].
    Ménégol-Couque B; Brard M
    Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative crossover study on the treatment of heartburn and epigastric pain: Liquid Gaviscon and a magnesium--aluminium antacid gel.
    Chevrel B
    J Int Med Res; 1980; 8(4):300-2. PubMed ID: 6250928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux.
    Barnardo DE; Lancaster-Smith M; Strickland ID; Wright JT
    Curr Med Res Opin; 1975; 3(6):388-91. PubMed ID: 1183220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The suppression of gastro-oesophageal reflux by alginates.
    Dettmar PW; Hampson FC; Taubel J; Lorch U; Johnstone LM; Sykes J; Berry PJ
    Int J Clin Pract; 2007 Oct; 61(10):1654-62. PubMed ID: 17681004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reflux esophagitis. A comparison of old and new medical management.
    Grossmann AE; Klotz AP; Rhodes JB; Korb T
    J Kans Med Soc; 1973 Nov; 74(11):423-4. PubMed ID: 4357380
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment with sodium alginate of gastroesophageal reflux disease in childhood: efficacy and tolerance assessment].
    Maestri L
    Pediatr Med Chir; 2001; 23(3-4):187-9. PubMed ID: 11723856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Arch Dis Child; 1992 May; 67(5):618-21. PubMed ID: 1599300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Peptic esophagitis, complication of gastro-esophageal reflux. A new treatment: Gaviscon].
    Monin E; Chevrel B
    Med Chir Dig; 1975; 4 suppl 2():67-71. PubMed ID: 1219249
    [No Abstract]   [Full Text] [Related]  

  • 33. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
    Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
    Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.
    Washington N; Greaves JL; Iftikhar SY
    Aliment Pharmacol Ther; 1992 Oct; 6(5):579-88. PubMed ID: 1420749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The alginate raft: a scintigraphic evaluation.
    McKay AP; Wraight EP; Hunter JO
    Br J Clin Pract Suppl; 1989 Feb; 66():20-4; discussion 35-6. PubMed ID: 2511919
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of reflux oesophagitis.
    Hamill JJ
    Practitioner; 1983 Apr; 227(1378):637-9. PubMed ID: 6304672
    [No Abstract]   [Full Text] [Related]  

  • 37. [Magnesium hydroxide and aluminum hydroxide in the treatment of gastroesophageal reflux].
    Iacono G; Carroccio A; Montalto G; Cavataio F; Ippolito S; Kazmierska I; Balsamo V
    Minerva Pediatr; 1991 Dec; 43(12):797-800. PubMed ID: 1798406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
    Kim SE; Park MI
    Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
    [No Abstract]   [Full Text] [Related]  

  • 39. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
    Onuchina EV; Brikova SI; Tsukanov VV
    Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.